← Back
Data updated: Mar 29, 2026
SEAGEN
OncologyGastroenterologyImmunology
Biotech
SEAGEN is a biotechnology company focused on Oncology, Gastroenterology, Immunology. Key products include TUKYSA.
2020
Since
2
Drugs
-
Trials
2
Approved (2yr)
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Competitive Matchups Pro
Loading...
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 87%
2 drugs Phase 3: 8 Phase 2: 22 Phase 1: 28
Gastroenterology 11%
0 drugs Phase 2: 4 Phase 1: 6
Immunology 2%
0 drugs Phase 2: 1 Phase 1: 1
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
Pfizer big-pharma
Oncology, Immunology, Gastroenterology
Bristol-Myers Squibb big-pharma
Oncology, Immunology, Gastroenterology
Takeda big-pharma
Immunology, Oncology, Gastroenterology
Gilead Sciences biotech
Oncology, Immunology, Gastroenterology
ASTELLAS specialty
Oncology, Gastroenterology, Immunology